Holdings of SILVERARC CAPITAL MANAGEMENT, LLC
58 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 54.1 % of the equity sleeve
Sector breakdown
- Health care 2.0 %
- Unattributed 98.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 91.7 %
- FR 4.4 %
- DK 3.7 %
- GB 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 55 | 704.1M $ | 91.68 % |
| 2 | FR | 1 | 33.7M $ | 4.39 % |
| 3 | DK | 1 | 28.5M $ | 3.71 % |
| 4 | GB | 1 | 1.7M $ | 0.22 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | KalVista Pharmaceuticals Inc | 2,876,407 | 57.9M $ | |
| 2 | Dianthus Therapeutics Inc | 654,746 | 54.9M $ | |
| 3 | Cogent Biosciences Inc | 1,314,189 | 50.6M $ | |
| 4 | Celcuity Inc | 357,903 | 40.9M $ | |
| 5 | Immunome Inc | 1,850,278 | 40.5M $ | |
| 6 | Kodiak Sciences Inc | 991,930 | 37.8M $ | |
| 7 | Nuvalent Inc | 354,914 | 36.4M $ | |
| 8 | Abivax SA | 302,530 | 33.7M $ | |
| 9 | Monte Rosa Therapeutics Inc | 2,002,040 | 32.9M $ | |
| 10 | Erasca Inc | 1,851,812 | 30M $ | |
| 11 | Ascendis Pharma A/S | 124,658 | 28.5M $ | |
| 12 | Rhythm Pharmaceuticals Inc | 306,000 | 26.6M $ | |
| 13 | Praxis Precision Medicines Inc | 71,552 | 23.1M $ | |
| 14 | ZENAS BIOPHARMA INC | 1,135,935 | 22.2M $ | |
| 15 | Syndax Pharmaceuticals Inc | 888,987 | 20.8M $ | |
| 16 | CENTESSA PHARMACEUTICALS PLC | 466,345 | 18.5M $ | |
| 17 | Scholar Rock Holding Corp | 339,613 | 16.7M $ | |
| 18 | ORIC Pharmaceuticals Inc | 1,100,010 | 13.9M $ | |
| 19 | Disc Medicine Inc | 196,028 | 12.5M $ | |
| 20 | CG oncology Inc | 166,349 | 11.3M $ | |
| 21 | Immunovant Inc | 414,236 | 10.3M $ | |
| 22 | Spyre Therapeutics Inc | 186,618 | 9.4M $ | |
| 23 | Biogen Inc | 50,967 | 9.3M $ | |
| 24 | Guardant Health Inc | 98,514 | 9.1M $ | |
| 25 | Vaxcyte Inc | 144,981 | 8.4M $ | |
| 26 | Savara Inc | 1,430,982 | 7.8M $ | |
| 27 | Benitec Biopharma Inc | 717,725 | 7.6M $ | |
| 28 | Oruka Therapeutics Inc | 150,908 | 7.4M $ | |
| 29 | Trevi Therapeutics Inc | 511,127 | 6.1M $ | |
| 30 | Insmed Inc | 35,850 | 5.9M $ | |
| 31 | Veracyte Inc | 179,700 | 5.8M $ | |
| 32 | Cerus Corp | 3,176,547 | 5.8M $ | |
| 33 | Celldex Therapeutics Inc | 178,378 | 5.7M $ | |
| 34 | C4 Therapeutics Inc | 1,911,785 | 5M $ | |
| 35 | Cytokinetics Inc | 71,203 | 4.7M $ | |
| 36 | Climb Bio Inc | 684,908 | 4.7M $ | |
| 37 | Compass Therapeutics Inc | 859,049 | 4.5M $ | |
| 38 | Surrozen Inc | 144,255 | 4.2M $ | |
| 39 | Contineum Therapeutics Inc | 301,729 | 3.9M $ | |
| 40 | Fulcrum Therapeutics Inc | 419,949 | 3.2M $ | |
| 41 | Abeona Therapeutics Inc | 648,942 | 2.9M $ | |
| 42 | CAMP4 THERAPEUTICS CORP | 653,594 | 2.9M $ | |
| 43 | Annexon Inc | 496,461 | 2.8M $ | |
| 44 | ELUTIA INC | 2,498,020 | 2.6M $ | |
| 45 | Monopar Therapeutics Inc | 43,488 | 2.4M $ | |
| 46 | Ovid therapeutics Inc | 1,000,000 | 2.2M $ | |
| 47 | NextCure Inc | 176,057 | 1.9M $ | |
| 48 | Compass Pathways plc | 300,000 | 1.7M $ | |
| 49 | Neumora Therapeutics Inc | 818,156 | 1.6M $ | |
| 50 | Sionna Therapeutics Inc | 39,417 | 1.6M $ | |
| 51 | TELA BIO INC | 2,259,312 | 1.4M $ | |
| 52 | Edgewise Therapeutics Inc | 42,615 | 1.3M $ | |
| 53 | Replimune Group Inc | 171,936 | 1.3M $ | |
| 54 | Generate Biomedicines Inc | 100,000 | 1.3M $ | |
| 55 | Fractyl Health Inc | 1,701,625 | 779K $ | |
| 56 | IBIO INC | 226,000 | 429.4K $ | |
| 57 | ADAGIO MEDICAL HOLDINGS INC | 251,972 | 289.8K $ | |
| 58 | Aardvark Therapeutics Inc | 33,684 | 127K $ | |